5.4(top 5%)
2-year impact
5.8(top 5%)
3-year impact
6.7(top 2%)
5-year impact
6.1(top 2%)
10-year impact
2.0K(top 10%)
PR articles
92.3K(top 5%)
PR citations
137(top 2%)
PR h-index
151(top 2%)
h-index
5.9(top 5%)
extended IF
5.6(top 2%)
2-YI (article-only)
8.6(top 20%)
2-YI (review-only)
5.3(top 5%)
2-YI (no self-cite.)
2.6K
documents
114.7K
doc citations

Top Articles

#TitleJournalYearPR Citations
1Forecasting the Impact of Heart Failure in the United StatesCirculation: Heart Failure20132,165
2Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection FractionCirculation: Heart Failure2010840
3Management of Acute Myocarditis and Chronic Inflammatory CardiomyopathyCirculation: Heart Failure2020567
4Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection FractionCirculation: Heart Failure2011513
5Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac ArrestCirculation: Heart Failure2018420
6Left Atrial Remodeling and Function in Advanced Heart Failure With Preserved or Reduced Ejection FractionCirculation: Heart Failure2015397
7Exercise Training in Patients With Heart Failure and Preserved Ejection FractionCirculation: Heart Failure2015393
8Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac AmyloidosisCirculation: Heart Failure2019391
9Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?Circulation: Heart Failure2012384
10Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial FibrogenesisCirculation: Heart Failure2013370
11Recent National Trends in Readmission Rates After Heart Failure HospitalizationCirculation: Heart Failure2010343
12Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection FractionCirculation: Heart Failure2014331
13Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection FractionCirculation: Heart Failure2015328
14PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart FailureCirculation: Heart Failure2011319
15Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic CardiomyopathyCirculation: Heart Failure2010315
16Exercise Training in Older Patients With Heart Failure and Preserved Ejection FractionCirculation: Heart Failure2010314
17Classification of Heart Failure in the Atherosclerosis Risk in Communities (ARIC) StudyCirculation: Heart Failure2012307
18Choline Diet and Its Gut Microbe–Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload–Induced Heart FailureCirculation: Heart Failure2016303
19Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 SignalingCirculation: Heart Failure2009292
20Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing ModelCirculation: Heart Failure2009289
21High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart FailureCirculation: Heart Failure2011289
22National Burden of Heart Failure Events in the United States, 2006 to 2014Circulation: Heart Failure2018286
23Modest Increase in Peak VO 2 Is Related to Better Clinical Outcomes in Chronic Heart Failure PatientsCirculation: Heart Failure2012285
24Predictors of New-Onset Heart FailureCirculation: Heart Failure2013285
25Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection FractionCirculation: Heart Failure2011280
26Cardiac Structure and Function in Heart Failure With Preserved Ejection FractionCirculation: Heart Failure2014278
27Echocardiography-Guided Left Ventricular Lead Placement for Cardiac Resynchronization TherapyCirculation: Heart Failure2013274
28Predicting Heart Failure With Preserved and Reduced Ejection FractionCirculation: Heart Failure2016272
29Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart FailureCirculation: Heart Failure2015270
30Prevalence of Left Ventricular Diastolic Dysfunction in a General PopulationCirculation: Heart Failure2009269
31Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart FailureCirculation: Heart Failure2008268
32Patterns of Disease Progression in Hypertrophic CardiomyopathyCirculation: Heart Failure2012265
33Cancer Therapy–Related Cardiac Dysfunction and Heart FailureCirculation: Heart Failure2016264
34Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination TherapyCirculation: Heart Failure2012263
35Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection FractionCirculation: Heart Failure2016262
36Comparative Safety and Effectiveness of Metformin in Patients With Diabetes Mellitus and Heart FailureCirculation: Heart Failure2013258
37The Development of Aortic Insufficiency in Left Ventricular Assist Device-Supported PatientsCirculation: Heart Failure2010257
38Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the RatCirculation: Heart Failure2014255
39Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection FractionCirculation: Heart Failure2016254
40Analysis of Metabolic Remodeling in Compensated Left Ventricular Hypertrophy and Heart FailureCirculation: Heart Failure2010252
41Energy Metabolic Reprogramming in the Hypertrophied and Early Stage Failing HeartCirculation: Heart Failure2014249
42Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart FailureCirculation: Heart Failure2017248
43Loop Diuretics in Acute Decompensated Heart FailureCirculation: Heart Failure2009246
44Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk ModelCirculation: Heart Failure2013246
45Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic ShockCirculation: Heart Failure2013245
46Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection FractionCirculation: Heart Failure2012238
47Lifetime Analysis of Hospitalizations and Survival of Patients Newly Admitted With Heart FailureCirculation: Heart Failure2012238
48Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and HypertrophyCirculation: Heart Failure2015231
49Death in Heart FailureCirculation: Heart Failure2008230
50Loop Diuretic EfficiencyCirculation: Heart Failure2014230